LEON and Harro Höfliger Announce Strategic Collaboration for Global Distribution and After-Sales Service of Nanoencapsulation Equipment

19 February 2026 -- Planegg, Germany -- leon-nanodrugs GmbH (LEON), a leading developer of advanced nanoencapsulation technology and equipment, and Harro Höfliger, a global expert in pharmaceutical engineering and GMP-compliant production, announced a strategic collaboration to expand worldwide access to LEON’s FR-JET technology and portfolio of equipment. Under the agreement, Harro Höfliger becomes a non-exclusive global authorized commercialization and service partner for LEON’s products.

Through this partnership, customers gain access to comprehensive global service and support, leveraging Harro Höfliger’s decades of experience in GMP-compliant production. LEON’s game-changing equipment is now available worldwide, and worldwide after-sales service is guaranteed. They also benefit from scalable deployment solutions, enabling a seamless transition from early-stage development to full commercial supply. At the same time, LEON continues to provide agility and innovation, ensuring that its cutting-edge technologies are paired with the backing of a major industrial partner.

“This partnership represents a major step forward for LEON, enabling us to bring our innovative nanoencapsulation solutions to a global audience while maintaining our commitment to scientific excellence and technology leadership,” said Dr. Wolfgang Hofmann, CEO of LEON.

Thomas Weller, CEO at Harro Höfliger, adds: “Driving innovation in pharmaceutical manufacturing is at the heart of this collaboration. By pairing LEON’s pioneering nanoencapsulation technology with Harro Höfliger’s expertise in GMP production solutions, we reaffirm our role as a trusted partner for our customers and provide solutions to scale the manufacturing of advanced therapies efficiently and reliably.”
The collaboration is expected to generate significant commercial impact and growth potential for both companies. By combining LEON’s innovative technology with Harro Höfliger’s global reach, GMP expertise, and international sales and service network, the partnership is positioned to accelerate market penetration, improve the customer experience, and unlock substantial growth opportunities worldwide.

About LEON (leon-nanodrugs GmbH)
Based in Planegg/Munich, LEON specializes in the development and commercialization of scalable nanoparticle manufacturing technologies from discovery to GMP. Powered by its patented FR-JET mixing technology, LEON enables formulation-adaptive processes that reduce scale-up risk and ensure consistent product quality across development and commercial manufacturing. For further information, please visit leon-nanodrugs.com/.

About HARRO (Harro Höfliger Verpackungsmaschinen GmbH)
Harro Höfliger specializes in customer-oriented process and production solutions for pharmaceutical and medical applications. Core competencies include solutions for advanced therapies, aseptic processing, innovative dosing and inhalation technologies, as well as processing of web materials. The company also offers extensive services regarding process development and the entire product life cycle. Since being founded in 1975, the company with headquarters in Allmersbach im Tal (Germany) has been expanding continuously. In 2025, Harro Höfliger employs around 2,450 people worldwide, with an export rate of over 80 percent. For further information, please visit hoefliger.com.